Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BDSX · against 262 other Healthcare companies of similar size
Ranked #184 of 263 · scores higher than 29% of peers
Bars: peers in each 10-point band of the profitability score31 peers with a profitability score of 20–29, including BDSX · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | BDSX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 224 reported | -55.9% | -1.6% | 18% | 33% | |
| Operating marginHigher is better · 244 reported | -20.0% | 1.6% | 33% | 33% | |
| Return on assetsHigher is better · 266 reported | -29.1% | -1.2% | 22% | 33% | |
| Return on equityHigher is better · 248 reported | -540.0% | -2.6% | 2% | Context only | |
| Gross marginHigher is better · 280 reported | 82.5% | 36.7% | 88% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 261M USD | 98 | 97 | |
| 3 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 3 | 356M AUD (≈$235M) | 97 | 81 | |
| 5 | 592M ILS (≈$160M) | 96 | 84 | |
| 180 | 1.6B HKD (≈$209M) | 21 | 54 | |
| 180 | 365M USD | 21 | 41 | |
| 180 | 375M USD | 21 | 46 | |
| 180 | 285M USD | 21 | 38 | |
| 184 | 222M USD | 20 | 31 | |
| 184 | 106M EUR (≈$116M) | 20 | 46 | |
| 184 | 238M USD | 20 | 41 | |
| 184 | 299M USD | 20 | 38 | |
| 188 | 913M HKD (≈$117M) | 19 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score